Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Hinojosa, Ara E ^a   Caso, Javier R ^b   García Bueno, Borja ^a   Leza, Juan C ^a   Madrigal, José L M ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Astrocytes; CCL2; CX3CL1; Fractalkine; Inflammation; MCP 1

Indexed keywords

CXCL16 CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CCL12 GENE; CCL2 GENE; CCL6 GENE; CCL7 GENE; CONTROLLED STUDY; CX3CL1 GENE; CXCL16 GENE; CYCLOOXYGENASE 2 GENE; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GAMMA INTERFERON GENE; GAPDH GENE; GENE EXPRESSION REGULATION; INTERLEUKIN 1BETA GENE; NEWBORN; NONHUMAN; PRIMARY CELL CULTURE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR ALPHA GENE;

EID: 84880025391     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-81     Document Type: Article

References (65)

1. Brunello N, Blier P, Judd LL, Mendlewicz J, Nelson CJ, Souery D, Zohar J, Racagni G. Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 2003, 18:191-202. 10.1097/00004850-200307000-00001, 12817153.
2. McIntyre CK, McGaugh JL, Williams CL. Interacting brain systems modulate memory consolidation. Neurosci Biobehav Rev 2012, 36:1750-1762. 10.1016/j.neubiorev.2011.11.001, 22085800.
3. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1214-1224. 10.1016/j.pnpbp.2005.08.007, 16226365.
4. O'Donnell J, Zeppenfeld D, McConnell E, Pena S, Nedergaard M. Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem Res 2012, 37:2496-2512. 10.1007/s11064-012-0818-x, 3548657, 22717696.
5. Feinstein DL, Heneka MT, Gavrilyuk V, Dello RC, Weinberg G, Galea E. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int 2002, 41:357-365. 10.1016/S0197-0186(02)00049-9, 12176079.
6. Weinshenker D. Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 2008, 5:342-345. 10.2174/156720508784533286, 18537547.
7. Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev 2004, 45:38-78. 10.1016/j.brainresrev.2004.02.002, 15063099.
8. Gee JR, Keller JN. Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int J Biochem Cell Biol 2005, 37:1145-1150. 10.1016/j.biocel.2004.10.004, 15778078.
9. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 2009, 29:263-267. 10.1523/JNEUROSCI.4926-08.2009, 19129402.
10. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 2010, 224:93-100. 10.1016/j.jneuroim.2010.05.010, 20681057.
11. Semple BD, Kossmann T, Morganti-Kossmann MC. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab 2010, 30:459-473. 10.1038/jcbfm.2009.240, 2949152, 19904283.
12. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 2003, 111:1185-1199. 10.1067/mai.2003.1594, 12789214.
13. Mehrad B, Keane MP, Strieter RM. Chemokines as mediators of angiogenesis. Thromb Haemost 2007, 97:755-762. 3353527, 17479186.
14. Belmadani A, Tran PB, Ren D, Miller RJ. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 2006, 26:3182-3191. 10.1523/JNEUROSCI.0156-06.2006, 2740990, 16554469.
15. Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A 2000, 97:8075-8080. 10.1073/pnas.090017497, 16672, 10869418.
16. Denes A, Ferenczi S, Halasz J, Kornyei Z, Kovacs KJ. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 2008, 28:1707-1721. 10.1038/jcbfm.2008.64, 18575457.
17. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 2010, 13:411-413. 10.1038/nn.2511, 20305648.
18. Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, Lamb BT. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol 2010, 177:2549-2562. 10.2353/ajpath.2010.100265, 2966811, 20864679.
19. Desforges NM, Hebron ML, Algarzae NK, Lonskaya I, Moussa CE. Fractalkine mediates communication between pathogenic proteins and microglia: implications of anti-inflammatory treatments in different stages of neurodegenerative diseases. Int J Alzheimers Dis 2012, 201(2):345472.
20. Madrigal JL, Dello RC, Gavrilyuk V, Feinstein DL. Effects of noradrenaline on neuronal NOS2 expression and viability. Antioxid Redox Signal 2006, 8:885-892. 10.1089/ars.2006.8.885, 16771678.
21. Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM, Wenk GL, Giovannini MG. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One 2012, 7:e45250. 10.1371/journal.pone.0045250, 3445467, 23028880.
22. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127. 10.1016/S1074-7613(00)80165-X, 10714678.
23. Rosito M, Deflorio C, Limatola C, Trettel F. CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS. J Neurosci 2012, 32:3154-3163. 10.1523/JNEUROSCI.4046-11.2012, 22378888.
24. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 1999, 163:3963-3968.
25. Figiel I. Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol Exp (Wars) 2008, 68:526-534.
26. Shaftel SS, Griffin WS, O'Banion MK. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 2008, 5:7. 10.1186/1742-2094-5-7, 2335091, 18302763.
27. Dello RC, Boullerne AI, Gavrilyuk V, Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammation 2004, 1:9. 10.1186/1742-2094-1-9, 500870, 15285793.
28. Re DB, Przedborski S. Fractalkine: moving from chemotaxis to neuroprotection. Nat Neurosci 2006, 9:859-861. 10.1038/nn0706-859, 16801915.
29. Kalinin S, Polak PE, Lin SX, Sakharkar AJ, Pandey SC, Feinstein DL. The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease. Neurobiol Aging 2012, 33:1651-1663. 10.1016/j.neurobiolaging.2011.04.012, 3646366, 21705113.
30. Traver S, Salthun-Lassalle B, Marien M, Hirsch EC, Colpaert F, Michel PP. The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol Pharmacol 2005, 67:1882-1891. 10.1124/mol.104.007864, 15784847.
31. Madrigal JL, Feinstein DL, Dello RC. Norepinephrine protects cortical neurons against microglial-induced cell death. J Neurosci Res 2005, 81:390-396. 10.1002/jnr.20481, 15948176.
32. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644. 10.1038/385640a0, 9024663.
33. Bruno V, Copani A, Besong G, Scoto G, Nicoletti F. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 2000, 399:117-121. 10.1016/S0014-2999(00)00367-8, 10884510.
34. Elhofy A, Wang J, Tani M, Fife BT, Kennedy KJ, Bennett J, Huang D, Ransohoff RM, Karpus WJ. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis. J Leukoc Biol 2005, 77:229-237.
35. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 2003, 85:1299-1311. 10.1046/j.1471-4159.2003.01775.x, 12753088.
36. Godefroy D, Gosselin RD, Yasutake A, Fujimura M, Combadiere C, Maury-Brachet R, Laclau M, Rakwal R, Melik-Parsadaniantz S, Bourdineaud JP, Rostène W. The chemokine CCL2 protects against methylmercury neurotoxicity. Toxicol Sci 2012, 125:209-218. 10.1093/toxsci/kfr252, 21976372.
37. Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ. MCP-1 protects mice in lethal endotoxemia. J Clin Invest 1997, 99:2832-2836. 10.1172/JCI119475, 508132, 9185504.
38. Kiyota T, Gendelman HE, Weir RA, Higgins EE, Zhang G, Jain M. CCL2 affects beta-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. Neurobiol Aging 2013, 34:1060-1068. 10.1016/j.neurobiolaging.2012.08.009, 23040664.
39. Ge S, Shrestha B, Paul D, Keating C, Cone R, Guglielmotti A, Pachter JS. The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis. J Neuroinflammation 2012, 9:171. 10.1186/1742-2094-9-171, 3488971, 22788993.
40. Yang G, Meng Y, Li W, Yong Y, Fan Z, Ding H, Wei Y, Luo J, Ke ZJ. Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol 2011, 21:279-297. 10.1111/j.1750-3639.2010.00445.x, 3046243, 21029241.
41. Madrigal JL, Garcia-Bueno B, Hinojosa AE, Polak P, Feinstein DL, Leza JC. Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. J Neurochem 2010, 113:543-551. 10.1111/j.1471-4159.2010.06623.x, 20132473.
42. Hinojosa AE, Garcia-Bueno B, Leza JC, Madrigal JL. Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of alpha2 adrenergic receptors. Brain Res Bull 2011, 86:326-333. 10.1016/j.brainresbull.2011.09.014, 21963947.
43. Koyama Y, Kotani M, Sawamura T, Kuribayashi M, Konishi R, Michinaga S. Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1. J Neuroinflammation 2013, 10:51. 10.1186/1742-2094-10-51, 3675376, 23627909.
44. O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol 2009, 12:687-699. 10.1017/S146114570800967X, 19046481.
45. Delaville C, Deurwaerdere PD, Benazzouz A. Noradrenaline and Parkinson's disease. Front Syst Neurosci 2011, 5:31. 3103977, 21647359.
46. Gustafson I, Westerberg E, Wieloch T. Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action. J Cereb Blood Flow Metab 1990, 10:885-894. 10.1038/jcbfm.1990.145, 1976642.
47. Polak PE, Kalinin S, Feinstein DL. Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2011, 134:665-677. 10.1093/brain/awq362, 3105488, 21297130.
48. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, Sastre M, Galldiks N, Zimmer A, Hoehn M, Heiss WD, Klockgether T, Staufenbiel M. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 2006, 26:1343-1354. 10.1523/JNEUROSCI.4236-05.2006, 16452658.
49. Fornai F, di Poggio AB, Pellegrini A, Ruggieri S, Paparelli A. Noradrenaline in Parkinson's disease: from disease progression to current therapeutics. Curr Med Chem 2007, 14:2330-2334. 10.2174/092986707781745550, 17896981.
50. Duan RS, Yang X, Chen ZG, Lu MO, Morris C, Winblad B, Zhu J. Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice. Neurochem Res 2008, 33:1085-1089. 10.1007/s11064-007-9554-z, 18095157.
51. Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT, Feinstein DL. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging 2007, 28:1206-1214. 10.1016/j.neurobiolaging.2006.06.003, 16837104.
52. Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biol Psychiatry 2013, 73:454-463. 10.1016/j.biopsych.2012.06.013, 22883210.
53. Galea E, Reis DJ, Fox ES, Xu H, Feinstein DL. CD14 mediate endotoxin induction of nitric oxide synthase in cultured brain glial cells. J Neuroimmunol 1996, 64:19-28. 10.1016/0165-5728(95)00143-3, 8598386.
54. Guillemin G, Boussin FD, Croitoru J, Franck-Duchenne M, Le GR, Lazarini F, Dormont D. Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains. J Neurosci Res 1997, 49:576-591. 10.1002/(SICI)1097-4547(19970901)49:5<576::AID-JNR8>3.0.CO;2-8, 9302079.
55. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434. 10.1002/glia.20207, 15846805.
56. Chung IY, Benveniste EN. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 1990, 144:2999-3007.
57. Soliman ML, Combs CK, Rosenberger TA. Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes. J Neuroimmune Pharmacol 2013, 8:287-300. 10.1007/s11481-012-9426-4, 23233245.
58. Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 2004, 78:151-156. 10.1002/jnr.20266, 15378607.
59. Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol 2012, 7:42-59. 10.1007/s11481-011-9287-2, 21728035.
60. Schlachetzki JC, Fiebich BL, Haake E, de Oliveira AC, Candelario-Jalil E, Heneka MT, Hüll M. Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia. J Neuroinflammation 2010, 7:2. 10.1186/1742-2094-7-2, 2819253, 20064241.
61. Shi J, Wang Q, Johansson JU, Liang X, Woodling NS, Priyam P, Loui TM, Merchant M, Breyer RM, Montine TJ, Andreasson K. Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Ann Neurol 2012, 72:788-798. 10.1002/ana.23677, 22915243.
62. Thery C, Dobbertin A, Mallat M. Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a beta-adrenergic agonist. Glia 1994, 11:383-386. 10.1002/glia.440110411, 7960041.
63. Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, Baik EJ. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J Neurosci Res 2002, 70:97-107. 10.1002/jnr.10373, 12237868.
64. Akaike A, Kaneko S, Tamura Y, Nakata N, Shiomi H, Ushikubi F, Narumiya S. Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 1994, 663:237-243. 10.1016/0006-8993(94)91268-8, 7874506.
65. Cazevieille C, Muller A, Meynier F, Dutrait N, Bonne C. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem Int 1994, 24:395-398. 10.1016/0197-0186(94)90118-X, 7914788.